Copyright Notice
Attribution Statement: LactMed is a registered trademark of the U.S. Department of Health and Human Services.
Bookshelf ID: NBK500757PMID: 29999816
NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.
Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006-.
CASRN: 839712-12-8
Drug Levels and Effects
Summary of Use during Lactation
No information is available on the use of cariprazine during breastfeeding. Until more data become available, an alternate drug may be preferred, especially while nursing a newborn or preterm infant.
Drug Levels
Cariprazine is metabolized to two major active metabolites with a half-life of 2 to 4 days. Desmethylcariprazine has a half-life of 1 to 2 days, and didesmethylcariprazine has a half-life of 1 to 3 weeks. Both are considered to be equipotent to cariprazine. The drug and metabolites are all >90% bound to plasma proteins.
Maternal Levels. Relevant published information was not found as of the revision date.
Infant Levels. Relevant published information was not found as of the revision date.
Effects in Breastfed Infants
Relevant published information was not found as of the revision date.
Effects on Lactation and Breastmilk
Relevant published information was not found as of the revision date. Cariprazine has little to no effect on serum prolactin levels.
Alternate Drugs to Consider
Substance Identification
Substance Name
Cariprazine
CAS Registry Number
839712-12-8
Drug Class
- Breast Feeding
- Antipsychotic Agents
Disclaimer: Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. The U.S. government does not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.
- User and Medical Advice Disclaimer
- Drugs and Lactation Database (LactMed) - Record Format
- LactMed - Database Creation and Peer Review Process
- Fact Sheet. Drugs and Lactation Database (LactMed)
- Drugs and Lactation Database (LactMed) - Glossary
- LactMed Selected References
- Drugs and Lactation Database (LactMed) - About Dietary Supplements
- Breastfeeding Links
- PubChem SubstanceRelated PubChem Substances
- Review Cilostazol.[Drugs and Lactation Database (...]Review Cilostazol.. Drugs and Lactation Database (LactMed®). 2006
- Cariprazine (RGH-188), a potent D3/D2 dopamine receptor partial agonist, binds to dopamine D3 receptors in vivo and shows antipsychotic-like and procognitive effects in rodents.[Neurochem Int. 2011]Cariprazine (RGH-188), a potent D3/D2 dopamine receptor partial agonist, binds to dopamine D3 receptors in vivo and shows antipsychotic-like and procognitive effects in rodents.Gyertyán I, Kiss B, Sághy K, Laszy J, Szabó G, Szabados T, Gémesi LI, Pásztor G, Zájer-Balázs M, Kapás M, et al. Neurochem Int. 2011 Nov; 59(6):925-35. Epub 2011 Jul 13.
- Review Itraconazole.[Drugs and Lactation Database (...]Review Itraconazole.. Drugs and Lactation Database (LactMed®). 2006
- Review Vilazodone.[Drugs and Lactation Database (...]Review Vilazodone.. Drugs and Lactation Database (LactMed®). 2006
- Review Rotigotine.[Drugs and Lactation Database (...]Review Rotigotine.. Drugs and Lactation Database (LactMed®). 2006
- Cariprazine - Drugs and Lactation Database (LactMed®)Cariprazine - Drugs and Lactation Database (LactMed®)
Your browsing activity is empty.
Activity recording is turned off.
See more...